Abstract
Enteral stents (ES) have emerged as first-line therapy for the treatment of malignant gastric outlet obstruction (GOO) and can offer durable symptom palliation with high rates of technical and clinical success. In patients with appreciable anticipated survival, however, tissue ingrowth may result in stent occlusion and recurrent GOO. The objective of this study was to compare rates of stent failure and reintervention following palliative ES for patients with GOO due to pancreatic adenocarcinoma (PDAC) versus other malignant etiologies.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
